Login
$NEUP
$3.39 +$0.01 (0.3%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2026
As of Jun 30, 2026
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Q4 FY2025
As of Jun 30, 2025
Q3 FY2025
As of Mar 31, 2025
Q2 FY2025
As of Dec 31, 2024
Q1 FY2025
As of Sep 30, 2024
Q4 FY2024
As of Jun 30, 2024
Q4 FY2023
As of Jun 30, 2023
Q4 FY2022
As of Jun 30, 2022
Research and development incentives receivable
Current assets:
Cash and cash equivalents
Accounts receivable, non-trade
Restricted cash
Prepaid expenses
Total current assets
Property and equipment, net
Intangible assets, net
Operating lease right-of-use assets
Restricted cash
Goodwill
Total assets
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Operating lease liability
Total current liabilities
Operating lease liability, net of current portion
Contingent consideration
Deferred tax liability
Accompanying warrant liability
Other non-current liabilities
Total liabilities
Shareholders’ equity:
Common stock, $0.00001 par value, 5,411,334 and 1,978,460 shares issued and outstanding at June 30, 2026 and 2025, respectively
Additional paid in capital, net of subscription receivable
Accumulated other comprehensive loss, net of tax
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support